Neophar Pharmaceuticals Private Limited
Founded in 2023 and headquartered in Delhi, India.
2023 | Delhi (India) | Active
Neophar Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 6 Months
About Neophar Pharmaceuticals
Neophar Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 October 2023 (One year and six months 30 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ruby Rani and Manish Kumar serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U21001DL2023PTC421633
- Company No.
421633
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Paper
Neophar Pharmaceuticals Private Limited
Explore comprehensive data for Neophar Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Neophar Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ruby Rani  | Director | 19-Oct-2023 | Current |
| Manish Kumar | Director | 19-Oct-2023 | Current |
Financial Performance of Neophar Pharmaceuticals.
Enhance accessibility to Neophar Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Neophar Pharmaceuticals?
Unlock access to Neophar Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Medsign Biotech Private LimitedManish Kumar is a mutual person
- Dietisure Nutraceuticals Private Limited
Manish Kumar is a mutual person
- Pharmaco Pharmaceuticals Private Limited
Manish Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neophar Pharmaceuticals?
Unlock and access historical data on people associated with Neophar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neophar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neophar Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Neophar Pharmaceuticals
Recent activity within the organization
- Director Appointment
Ruby Rani was appointed as a Director was appointed as a Director on 19 Oct 2023 & has been associated with this company since 1 year 6 months .
- Director Appointment
Manish Kumar was appointed as a Director was appointed as a Director on 19 Oct 2023 & has been associated with this company since 1 year 6 months .
- Company Incorporation
Neophar Pharmaceuticals Private Limited was registered on 19 Oct 2023 with Roc Delhi & aged 1 year 6 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Neophar Pharmaceuticals Private Limited?
Neophar Pharmaceuticals Private Limited was incorporated on 19 Oct 2023.
What is authorized share capital and paid-up capital of Neophar Pharmaceuticals Private Limited?
The authorized share capital of Neophar Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Neophar Pharmaceuticals Private Limited?
Currently 2 directors are associated with Neophar Pharmaceuticals Private Limited.
- Ruby Rani
- Manish Kumar
What is the registered address of Neophar Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Neophar Pharmaceuticals Private Limited is Plot No 221 Ground Floor Pkt H Sector-1 Bawana, India, Delhi, 110039.
What is the corporate identification number (CIN) and company number of Neophar Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Neophar Pharmaceuticals Private Limited is U21001DL2023PTC421633 and the company number is 421633 as per Ministry of Corporate Affairs (MCA).
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records